All Articles

On a daily basis, navigators are asked to provide many varied, and sometimes very novel, services for their patients, according to Penny Daugherty, RN, MS, OCN, ONN-CG, an oncology nurse navigator at the Northside Hospital Cancer Institute in Atlanta.

A Roadmap for Professional Growth: A Sarah Cannon Initiative

By Stephen Mazer, MSN, RN-BC, OCN, ONN-CG; Katie Farley, BSN, RN, OCN, ONN-CG

September 2021 Vol 12, No 9

The Sarah Cannon model to support navigators in their careers.

Patient Empowerment: A Process, Not a Destination

By Julia Burford, BSN, RN, ONN-CG

Patient Advocacy/Empowerment

September 2021 Vol 12, No 9

You are in a prime position to empower patients to have meaningful communication and involvement in their own care. Here’s how.

Biden Jabs at Pharma Drug prices are falling, but the President needs a foil for inflation.

September 2021 Vol 12, No 9

President Biden is worried inflation is undermining public support for his agenda so he’s rounding up the usual villains.

Best Practices in GU Navigation

Educating Patients About First-Line Treatment Options for Advanced Renal-Cell Carcinoma

By Laura Wood, RN, MSN, OCN; Megan Price, MSN, APRN, FNP-C; Virginia Seery, CRNP, MSN

Interview with the Innovators

Video Library

Megan Price, MSN, APRN, FNP-C, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, discuss their approach to conversations with patients and families regarding first-line therapy for advanced renal-cell carcinoma. They also describe what resources they share with patients to help them after the initial consultation.

Biomarker Testing Is Underutilized Prior to Frontline Testing in Patients with NSCLC

Lung Cancer

Web Exclusives

Despite guideline recommendations, a retrospective study found inadequate biomarker testing rates to direct targeted therapy.

Review Article Highlights Research Advances in NSCLC Harboring KRAS G12C Mutation

Lung Cancer

Web Exclusives

Researchers highlighted promising research into early-stage diagnostics and therapies for NSCLC harboring the KRAS G12C mutation discussed in a review article.

Chronic Pneumonitis in Patients with NSCLC Treated with Immune Checkpoint Inhibitor Therapy

Lung Cancer

Web Exclusives

A recent study found that chronic pneumonitis is a rare complication of immune checkpoint inhibitor therapy in patients with NSCLC.

Study Reveals Racial Disparity in NGS Testing in Patients with NSCLC

Lung Cancer

Web Exclusives

A retrospective analysis demonstrated a 10-point difference in receipt of NGS testing between white and black patients with NSCLC.

AONN+ 12th Annual Navigation & Survivorship Conference. Join us for this virtual experience November 17-21!

By Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG

Letters from Lillie

August 2021 Vol 12, No 8

This November, we will welcome you back to our virtual platform as we host the premier event for oncology navigators: The AONN+ 12th Annual Navigation & Survivorship Conference!

All Articles

Page 101 of 283

Connect with Us

Subscribe Today!

I'd like to receive:

Please enter your mailing address.